|
Market Closed -
NYSE
00:00:02 21/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 60.21 USD | -4.03% |
|
-9.09% | -29.10% |
| 11-13 | Novo Holdings-backed Windward Bio raises $175 million in US IPO | RE |
| 11-09 | Novo-backed Windward Bio targets $1 billion valuation in US IPO | RE |
Company Valuation: Piper Sandler Companies
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,510 | 1,840 | 2,631 | 4,756 | 5,652 | 4,024 | - | - |
| Change | - | -26.71% | 42.99% | 80.79% | 18.83% | -28.81% | - | - |
| Enterprise Value (EV) 1 | 1,754 | 1,709 | 2,341 | 4,283 | 4,857 | 3,364 | 3,312 | 3,247 |
| Change | - | -2.57% | 37% | 82.93% | 13.4% | -30.75% | -1.54% | -1.96% |
| P/E | 10.9x | - | - | - | 21.5x | 14.8x | 13x | - |
| PBR | 2.37x | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | 5.09x | 0.9x | - |
| Capitalization / Revenue | 1.27x | 1.28x | 1.98x | 3.09x | 3.01x | 2.03x | 1.81x | 1.64x |
| EV / Revenue | 0.89x | 1.19x | 1.76x | 2.78x | 2.58x | 1.7x | 1.49x | 1.33x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | 3.19x | 6.35x | 11x | 14.1x | 11.8x | 7.96x | 6.64x | 5.61x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.4875 | 0.9125 | 0.85 | 1.375 | 1.925 | 2.058 | 1.927 | 2.74 |
| Rate of return | 1.09% | 2.8% | 1.94% | 1.83% | 2.27% | 3.42% | 3.2% | 4.55% |
| EPS 2 | 4.108 | - | - | - | 3.955 | 4.07 | 4.63 | - |
| Distribution rate | 11.9% | - | - | - | 48.7% | 50.6% | 41.6% | - |
| Net sales 1 | 1,980 | 1,434 | 1,330 | 1,541 | 1,879 | 1,980 | 2,222 | 2,450 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | 550 | 269.2 | 212.9 | 303.7 | 410.7 | 422.8 | 498.5 | 578.3 |
| Net income 1 | - | - | - | - | 281.3 | 280.4 | 312.7 | - |
| Net Debt 1 | -756.3 | -130.9 | -289.4 | -472.8 | -794.4 | -659.9 | -711.6 | -776.4 |
| Reference price 2 | 44.63 | 32.55 | 43.72 | 74.99 | 84.93 | 60.21 | 60.21 | 60.21 |
| Nbr of stocks (in thousands) | 56,251 | 56,526 | 60,174 | 63,422 | 66,545 | 66,825 | - | - |
| Announcement Date | 2/10/22 A | 2/3/23 A | 2/2/24 A | 1/31/25 A | 2/6/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 14.79x | 1.7x | - | 3.42% | 4.02B | ||
| 12.83x | 5.98x | - | 2.6% | 259B | ||
| 11.04x | 9.42x | - | 2.41% | 237B | ||
| 9.7x | - | - | 2.28% | 183B | ||
| 14.58x | 5.24x | 8.69x | 1.42% | 156B | ||
| 10.11x | 1.49x | - | 3.57% | 54.91B | ||
| 19.36x | 10.74x | 12.23x | 0.68% | 43.64B | ||
| 9.55x | 3.97x | - | 3.4% | 40.35B | ||
| 9.59x | 6.81x | 11.03x | 3.42% | 40.19B | ||
| 26.15x | 3.57x | 4.52x | 0.57% | 32.26B | ||
| Average | 13.77x | 5.44x | 9.12x | 2.38% | 105B | |
| Weighted average by Cap. | 12.44x | 6.58x | 9.11x | 2.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- PIPR Stock
- Valuation Piper Sandler Companies
Select your edition
All financial news and data tailored to specific country editions
















